Melissa Tracy to Humans
This is a "connection" page, showing publications Melissa Tracy has written about Humans.
Connection Strength
0.114
-
Managing Ischemic Heart Disease in Women: Role of a Women's Heart Center. Curr Atheroscler Rep. 2021 08 04; 23(10):56.
Score: 0.011
-
Simulating the Suicide Prevention Effects of Firearms Restrictions Based on Psychiatric Hospitalization and Treatment Records: Social Benefits and Unintended Adverse Consequences. Am J Public Health. 2019 06; 109(S3):S236-S243.
Score: 0.009
-
Takotsubo cardiomyopathy in a man with no trigger and multiple cardioembolic complications-A rare constellation. Echocardiography. 2019 May; 36(5):975-979.
Score: 0.009
-
uPAR isoform 2 forms a dimer and induces severe kidney disease in mice. J Clin Invest. 2019 04 02; 129(5):1946-1959.
Score: 0.009
-
Use of ultrasound enhancing agents in transesophageal echocardiography to improve interpretive confidence of left atrial appendage thrombus. Echocardiography. 2019 02; 36(2):362-369.
Score: 0.009
-
Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab. BMC Nephrol. 2018 12 17; 19(1):361.
Score: 0.009
-
Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD. Clin J Am Soc Nephrol. 2018 07 06; 13(7):1013-1021.
Score: 0.009
-
Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein. J Am Heart Assoc. 2018 05 01; 7(9).
Score: 0.009
-
Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children. JAMA Pediatr. 2017 11 06; 171(11):e172914.
Score: 0.008
-
A tripartite complex of suPAR, APOL1 risk variants and av?3 integrin on podocytes mediates chronic kidney disease. Nat Med. 2017 Aug; 23(8):945-953.
Score: 0.008
-
Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial. Circ Res. 2014 Apr 11; 114(8):1292-301.
Score: 0.006
-
Comparison of allogeneic vs autologous bone marrow?derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012 Dec 12; 308(22):2369-79.
Score: 0.006
-
Percutaneous mechanical thrombectomy of left atrial appendage thrombus with bilateral neuro-embolic protection followed by closure of left atrial appendage. EuroIntervention. 2012 Jul 20; 8(3):408-9.
Score: 0.006
-
Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy. Am Heart J. 2011 Mar; 161(3):487-93.
Score: 0.005